PTCOG Newsletter #5 | Early Carrier Researchers ECR - Particle Therapy Co-Operative Group (PTCOG)

Our Mission

Our mission is to promote science, technology and practical clinical application of particle therapy, with the ultimate goal of improving treatment of cancer to the highest possible standards in radiation therapy.

More about PTCOG

Particle Therapy centers

Facilities in Operation: Explore a comprehensive list of particle therapy centers worldwide that are currently operational.
Facilities under Construction: Discover upcoming particle therapy centers worldwide that are currently under construction
Facilities in Planning Stage: Learn about particle therapy centers in the planning phase
Facilities World Map: View a global map of particle therapy centers, providing an interactive overview of operational, under-construction, and planned facilities worldwide.

Clinical Practice

Patient Statistics: Access detailed patient statistics from particle therapy centers worldwide, offering insights into treatment trends, outcomes, and advancements in clinical practice.
Clinical Trials, Protocols: Explore ongoing clinical trials and established treatment protocols in particle therapy

PTCOG Early Career Researcher (ECR) Subcommittee

Our mission is to foster collaboration, provide support, and address the unique needs of those navigating their early careers in particle therapy.

The PTCOG Early Career Researcher (ECR) Subcommittee is a dedicated group representing the interests and concerns of emerging researchers and practitioners in PTCOG.

The PTCOG-ECR subcommittee has three co-chairs. These are elected yearly during the general subcommittee meeting at the annual PTCOG conference. A subgroup of ECR members, the Operative Group, is formed annually to actively organize, make decisions, and come up with ideas for activities related to the ECR. The engagement of the whole ECR subcommittee is stimulated by tools like polls, newsletters, and feedback forms, allowing a constant flow of ideas and suggestions.

Learn more